E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Publication of Investigator-Initiated Trial Data for SAVIOR-1 in COVID-19 Patients in Frontiers in Neurology
21 avr. 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., April 21, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Frontiers in Neurology has published...
Vice Admiral (r) Timothy Szymanski
Odyssey Health Welcomes United States Vice Admiral (r) Timothy Szymanski to Military Advisory Board
20 avr. 2022 08h30 HE | Odyssey Group Intl Inc.
Irvine, CA, April 20, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc., formerly known as Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) Selected for Department of Defense Biotech Optimized for Operational Solutions and Tactics (BOOST) Program
19 avr. 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore™ nVNS has been selected for...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Provides Business Update and Select First Quarter 2022 Financial Guidance
12 avr. 2022 08h00 HE | electroCore, Inc.
Record revenue from product sales will be approximately $1.9M; approximately 60% growth over first quarter 2021March 31, 2022, cash balance of approximately $29.9M ROCKAWAY, N.J., April 12, 2022 ...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Exclusive License Agreement with Teijin for Japan Territory
05 avr. 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., April 05, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced it has entered into an...
James “Jim” Linder: Major General USA (r) Former Chief of Staff USSOCOM
Odyssey Group International Announces Formation of Military Advisory Board and Welcomes Prestigious Members to Assist with Concussion Drug Development
31 mars 2022 08h30 HE | Odyssey Group Intl Inc.
Irvine, CA, March 31, 2022 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products,...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Dr. Peter Staats to Keynote the Fifth Annual Bioelectronic Medicine Forum in New York
23 mars 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced its co-founder and Chief...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Present at 2022 Maxim Virtual Growth Conference
22 mars 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Fourth Quarter and Full Year 2021 Financial Results
10 mars 2022 16h01 HE | electroCore, Inc.
Full year 2021 net sales of approximately $5.5 million increased 56% over $3.5 million for full year 2020 Ended 2021 with cash and cash equivalents of $34.7 million Company to host conference call...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Changes to its Board of Directors
09 mars 2022 11h30 HE | electroCore, Inc.
ROCKAWAY, N.J., March 09, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the appointment of Julie Bruzzone Goldstein...